found that decreased transcription and expression of ATG2B was related to ER/PR-negative breast cancer, and methylation of ATG2B was also correlated with high-grade and TNM stage in invasive ductal carcinomas (28). This evidence concerns the gene ATG2B and invasive ductal breast carcinoma.